500
PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, is pleased to provide this update. Our focus is on building shareholder value by pursuing pre-market approval for SkinTE® from the U.S. Food and Drug Administration (FDA) through submission of an investigational new drug application (IND) and eventual biologics license application (BLA), and protecting our intellectual property.
Regulatory Update
Over the last several months, the Company has had meaningful interactions with the FDA regarding the Company’s planned IND for SkinTE. Through these interactions the Company gained valuable insight regarding the critical information it expects to include in the IND, and believes it remains on track to file the IND for SkinTE in the second half of 2021.
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of QuantumScape Corporation ("QuantumScape" or the "Company") (NYSE: QS) from November 27, 2020 through December 31, 2020 (the "Class Period"). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934. If you purchased QuantumScape securities, and/or would like to discuss your legal rights and options please visit QuantumScape Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com The complaint alleges that throughout the Class Period the Defendants made materially false and/or misleading statements, as well
Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action lawsuit for violations of the federal securities laws in the U.S. District Court for the Western District of Texas against SolarWinds Corporation ("SolarWinds" or the "Company") and certain of the Company's current and former senior executives (collectively, "Defendants"). The complaint expands the class period that was asserted in a previously-filed related securities class action pending against SolarWinds captioned Bremer v. SolarWinds Corporation, No. 1:21-cv-00002 (W.D. Tex.), and is brought on behalf of investors in SolarWinds common stock between October 18, 2018 and December 17, 2020, inclusive (the "Class Period").